Revista Medicina Nuclear Alasbimn Journal, Year 5, Nº 17, September, 2002

Year 5, N°17, September, 2002
Special Issue: World Congress of Nuclear Medicine

Abstracts

Article Nº AJ17-15

15.

RADIOPHARMACY

	M.G. Argüelles
15.01	PREPARATION AND EVALUATION OF HOLMIUM-166 FERRIC HYDROXIDE MACROAGGREGATES FOR RADIATION SYNOVECTOMY

	G.P. Bandopadhyaya
15.02	TC-99M LABELLED ALPHA MERCAPTO PROPIONYL GLYCINE (THIOLA) & PH VARIABLE BIODISTRIBUTION : AN EXPERIMENTAL APPROACH

	M.F. Barboza
15.03	SYNTHESIS AND QUALITY CONTROL OF 18F-FDG AT IPEN-CNEN/SP

	M.F. Barboza
15.04	PRODUCTION AND QUALITY CONTROL OF 123I-MIBG AT IPEN-CNEN/SP

	J. Booij
15.05	EVALUATION OF NEWLY SYNTHESIZED TZTP-DERIVATIVES AS POTENTIAL SPECT TRACERS FOR IMAGING MUSCARINIC M2 RECEPTORS

	C. Calderón
15.06	DOSE FRACTIONATING IN BETA-EMITTERS RADIONUCLIDE THERAPY

	M.C. Chandia
15.07	PRODUCCTION AND EVALUATION OF LABELED BISPHOSPHONATES WITH 153SM,166HO AND 177LU AS THERAPEUTIC RADIOPHARMACEUTICALS

	M.C. Chandía
15.08	166HO-HA EVALUATION AS THERAPEUTIC AGENT FOR RHEUMATOID ARTHRITIS TREATMENT

	J.L. Coffey
15.09	TEN YEARS OF ALARA EXPERIENCE IN COMMERCIAL NUCLEAR PHARMACY

	J.L. Crudo
15.10	99MTC-UBI 29-41 SEEMS TO BE AN EFFICIENT AGENT FOR IMAGING INFECTED MICE

	C.A. Custódio
15.11	A HIGH RESOLUTION GAS CHROMATOGRAPHIC METHOD FOR THE SOLVENT ANALYSIS IN THE 18-FDG ( 2-[18-F]- FLUORO-2 -DEOXY-D-GLUCOSE )SYNTHESIS

	D.K. Dhawan
15.12	EFFECTIVENESS OF ZINC IN REGULATING THYROID FUNCTION FOLLOWING I-131 TREATMENT TO WISTAR RAT

	D.K. Dhawan
15.13	INFLUENCE OF ZINC ON THE BIOKINETICS OF ZN-65 AND HEPATIC TRACE ELEMENTS OF ETHANOL TREATED RATS

	G.F. Diré
15.14	AN IN VITRO ANALYSIS OF THE EFFECT OF EXTRACTS OF NATURAL PRODUCTS (CAULIFLOWER AND CHAYOTTE) ON THE LABELING OF LYMPHOCYTES WITH TECHNETIUM-99M

	A. Duatti
15.15	RHENIUM-188 LIPIODOL KIT FORMULATION FOR THERAPY OF HEPATOCELLULAR CARCINOMA (HCC)

	A. Durakovic
15.16	ESTIMATE OF THE TIME-ZERO LUNG BURDEN OF DEPLETED URANIUM IN GULF WAR VETERANS BY THE 24 HOUR URINARY EXCRETION AND EXPONENTIAL DECAY ANALYSIS

	G. Ferro-Flores
15.17	PREPARATION AND EVALUATION OF RADIOPHARMACEUTICALS FOR INFECTION IMAGING

	G. Ferro-Flores
15.18	LABELING OF BIOTIN WITH DY-166/HO-166 AS A STABLE IN VIVO GENERATOR SYSTEM

	R.S.F. Freitas
15.19	EVALUATION OF THE IN VIVO BINDING OF 99MTC-MDP ON SERUM PROTEINS.

	N.O. Godoy
15.20	THE 166HO AND 177LU PRODUCTION FOR NUCLEAR MEDICINE APPLICATIONS AT THE RECH-1

	S. Guhlke
15.21	NEW LHRH ANALOGS FOR THE DETECTION OF LHRH POSITIVE TUMORS

	T. Haradahira
15.22	DEVELOPMENTS OF PET RADIOLIGANDS FOR NMDA RECEPTORS

	K. Horiuchi
15.23	SPECIFICITY OF PH SENSITIVE TC(V)-DMS FOR ACIDOPHILIC OSTEOCLASTIC BONE CELLS: BIOLOGICAL AND CELLULAR STUDIES

	A.R. Ketring
15.24	PRODUCTION AND SUPPLY OF HIGH SPECIFIC ACTIVITY RADIOISOTOPES FOR RADIOTHERAPY APPLICATIONS

	K. Kucheria
15.25	DIAGNOSIS, PROGNOSIS AND DISEASE MANAGEMENT USING IN SITU HYBRIDIZATION

	R. Leyva Montaña
15.26	SPECTROPHOTOMETRIC DETERMINATION OF METHYLENE DIPHOSPHONIC ACID (MDP) IN MDP-SN KITS

	R. Leyva Montaña
15.27	LABELING OF HUMANIZED MAB H-R3 WITH Y-90

	Z.L. Li
15.28	PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OF LEVOTHYROXINE SODIUM TABLETS BY RIA

	L. Li
15.29	THE MEASUREMENT OF SAMARIUM-153-EDTMP BONE UPTAKE RATE AND ITS RELATIONSHIP WITH THERAPEUTIC EFFECT

	K. Liepe
15.30	WHICH IS THE FAVORABLE TIME FOR DOSIMETRY AFTER 188RE-HEDP APPLICATION

	S.J. Mather
15.31	VIRRAD - THE VIRTUAL RADIOPHARMACY - A VIRTUAL LEARNING COMMUNITY IN RADIOPHARMACY

	D.H. Moon
15.32	IMAGING OF ADENOVIRUS-MEDIATED EXPRESSION OF HUMAN SODIUM IODIDE SYMPORTER GENE BY TC-99M PERTECHNETATE SCINTIGRAPHY IN MICE

	M. Neves
15.33	MOLECULAR MODELLING AND RADIOPHARMACEUTICAL DESIGN

	R. Oltenfreiter
15.34	BIOLOGICAL ACTIVITY DETERMINATION OF I-BSP, A POTENT MMP 2 INHIBITOR, AND ITS 123I TRACER SYNTHESIS

	J.A. Osso Junior
15.35	DEVELOPMENT OF 99MO-99MTC GEL TYPE GENERATORS AT IPEN-CNEN/SP

	A.M. Rey
15.36	DESIGN AND EVALUATION OF POTENTIAL BIORREDUCTIVE RADIOPHARMACEUTICALS BASED ON THE 3+1 MIXED LIGAND APPROACH

	M. Rodrigues
15.37	ACCUMULATION OF TC-99M-MIBI AND TC-99M-TETROFOSMIN IN TUMOR CELLS. UPTAKE AND WASHOUT STUDIES.

	S.M. Rubow
15.38	STABILISATION OF 99MTC-HMPAO WITH BUFFERED METHYLENE BLUE SOLUTION: IS IT FEASIBLE IN A FRACTIONATED KIT?

	C.D. Russell
15.39	A BAYESIAN COMPARTMENTAL MODEL FOR TC-99M-ETHYLENE DICYSTEINE (EC)

	S. Shahhosseini
15.40	REDUCTION OF IN VIVO DEIODINATION OF RADIOIODINATED ANTIBODIES USING N-SUCCINIMIDYL-4-[125I]IODOBENZOATE

	R. Spaic
15.41	REFERENT 3D TUMOR MODEL AT CELLULAR LEVEL IN RADIONUCLIDE THERAPY

	L. Staelens
15.42	SYNTHESIS AND IN VIVO EVALUATION OF [123I]-4-IODO-N-(4-(4-(2-METHOXYPHENYL)-PIPERAZIN-1-YL)BUTYL)-BENZAMIDE, A POTENTIAL SIGMA RECEPTOR LIGAND FOR SPECT STUDIES

	R.E. Touzet
15.43	THE USE OF 'REFERENCE LEVELS' IN NUCLEAR MEDICINE

	S. Vasquez
15.44	ANTIGENS AND MONOCLONAL ANTIBODIES LABELLING AND SOLID PHASE TO DETECT HEPATITIS B VIRUS INFECTION

	R.F. Wang
15.45	THE COMPARISON OF TC-99M-BPHA WITH TC-99M-DTPA ON THE PHARMACOKINETICS AND EVALUATION OF RENAL FUNCTION

	C.Y. Wu
15.46	SYNTHESIS AND RADIOLABELLING OF A NEW FLUORO ANOLOG OF WAY100635: 4-FLUORO-(2'-METHOXYPHENYL)-1-[2'-[N-(2''-PYRIDINYL)-P-BENZAMIDO]ETHYL]PIPERAZINE(18F-MPPF)

	C.Y. Wu
15.47	KINETIC STUDY ON LIGAND EXCHANGE REACTION BETWEEN ETHYLENEDICYSTEINE AND 99MTC- GLUCOHEPTONATE( 99MTC-GH)

	C.Y. Wu
15.48	THE PREPARATION AND EVALUATION OF 99M-TECHNITIUM LABELING P-[(N,N'-DI-CARBOXYMETHYL) AMINOMETHYL CARBOXYAMINO]-PHENYLPENTADECANOIC ACID 99MTC-CACPPA

	C.Y. Wu
15.49	PRECLINICAL EVALUATION ON IODINE-125-B METHYL IODIDE PHENYLPENTADECANOIC ACID(125I-BMIPP)

	Y.X. Zhang
15.50	TECHNETIUM-99M LABELED ANTISENSE PROBES UPTAKE IN VASCULAR SMOOTH MUSCLE CELLS

	C.L. Zhang
15.51	SYNTHESIS, ANTITUMOR ACTIVITY, TC-99M LABELING AND BIODISTRIBUTION OF NOVEL ORGANOGERMANIUM SESQUIOXIDES

	A.M. Zimmer
15.52	STABILITY OF Y-90 ZEVALIN: RADIOCHEMICAL PURITY EVALUATION USING INSTANT THIN LAYER AND SIZE EXCLUSION HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Sitio desarrollado por SISIB - Universidad de Chile